Michel Sabé
Impact in
- Psychiatry and Mental health top 2%
- Schizophrenia research and treatment
- Bipolar Disorder and Treatment
- Biological Psychiatry top 5%
- Tryptophan and brain disorders
Papers in
-
- Schizophrenia research and treatment 13
-
- Psychedelics and Drug Studies 7
- Mindfulness and Compassion Interventions 3
- Co-authors
- Stefan Kaiser (25 shared papers)Othman Sentissi (15 shared papers)Marco Solmi (18 shared papers)Chaomei Chen (8 shared papers)Armida Mucci (3 shared papers)Silvana Galderisi (3 shared papers)Alessio Crippa (4 shared papers)Wolfgang Gäebel (2 shared papers)
- Journals
- Neuroscience & Biobehavioral Reviews (5 papers)European Psychiatry (3 papers)European Neuropsychopharmacology (3 papers)Progress in Neuro-Psychopharmacology and Biological Psychiatry (3 papers)Schizophrenia Research (3 papers)
- Partner nations
- SwitzerlandUnited StatesGermany
In The Last Decade
Michel Sabé
40 papers receiving 1.1k citations
Michel Sabé's Hit Papers
Peers
Comparison fields: 5 of 136
- Psychiatry and Mental health 430
- Biological Psychiatry 71
- Clinical Psychology 217
- Experimental and Cognitive Psychology 129
- Philosophy 72
Countries citing papers authored by Michel Sabé
This map shows the geographic impact of Michel Sabé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michel Sabé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michel Sabé more than expected).
Fields of papers citing papers by Michel Sabé
This network shows the impact of papers produced by Michel Sabé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michel Sabé. The network helps show where Michel Sabé may publish in the future.
Co-authors
The 25 scholars most cited alongside Michel Sabé, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | EPA guidance on assessment of negative symptoms in schizophrenia Hit paper breakdown → | 2021 | 157 |
| 2 | Half a century of research on antipsychotics and schizophrenia: A scientometric study of hotspots, nodes, bursts, and trends Hit paper breakdown → | 2022 | 148 |
| 3 | EPA guidance on treatment of negative symptoms in schizophrenia Hit paper breakdown → | 2021 | 129 |
| 4 | 2022 | 58 | |
| 5 | 2019 | 56 | |
| 6 | 2022 | 56 | |
| 7 | 2019 | 56 | |
| 8 | 2023 | 52 | |
| 9 | 2021 | 48 | |
| 10 | 2022 | 39 | |
| 11 | 2022 | 36 | |
| 12 | 2021 | 28 | |
| 13 | 2023 | 28 | |
| 14 | 2020 | 27 | |
| 15 | 2023 | 27 | |
| 16 | 2024 | 26 | |
| 17 | 2023 | 19 | |
| 18 | 2019 | 18 | |
| 19 | 2024 | 17 | |
| 20 | 2021 | 16 |
About Michel Sabé
Michel Sabé is a scholar working on Psychiatry and Mental health, Clinical Psychology, Experimental and Cognitive Psychology, Cellular and Molecular Neuroscience and Cognitive Neuroscience, having authored 45 papers that have together received 1.2k indexed citations. Recurring topics across this work include Schizophrenia research and treatment (13 papers), Psychedelics and Drug Studies (7 papers), Neurotransmitter Receptor Influence on Behavior (5 papers), Functional Brain Connectivity Studies (5 papers), Mental Health Research Topics (4 papers), Tryptophan and brain disorders (4 papers), Neural dynamics and brain function (3 papers) and Mindfulness and Compassion Interventions (3 papers). The work is most often cited by research in Psychiatry and Mental health (430 citations), Biological Psychiatry (71 citations), Clinical Psychology (217 citations), Experimental and Cognitive Psychology (129 citations) and Philosophy (72 citations). Michel Sabé has collaborated with scholars based in Switzerland, United States and Germany. Frequent co-authors include Stefan Kaiser, Othman Sentissi, Marco Solmi, Chaomei Chen, Armida Mucci, Silvana Galderisi, Alessio Crippa, Wolfgang Gäebel, Merete Nordentoft and Pasquale Pezzella. Their work appears in journals such as Neuroscience & Biobehavioral Reviews, European Psychiatry, European Neuropsychopharmacology, Progress in Neuro-Psychopharmacology and Biological Psychiatry and Schizophrenia Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.